ArticleTherapeutic advances in infectious disease
SARS-CoV-2 N protein and anti-spike serologies: insights into COVID-19 disease severity and mortality-a secondary analysis of the ACTIV-1 trial.
Alfredo J Mena Lora et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.